Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers - Switzerland
doi 10.3390/cancers10120477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Breast Diseases
OncologySurgery
2013English

Intensive Breast Screening in BRCA2 Mutation Carriers Is Associated With Reduced Breast Cancer Specific and All Cause Mortality

Hereditary Cancer in Clinical Practice
OncologyGenetics
2016English

A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers

Current Oncology
Oncology
2014English

Methionine-Dependence Phenotype in the De Novo Pathway in BRCA1 and BRCA2 Mutation Carriers With and Without Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review With Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of BRCA1 and BRCA2 Mutation Carriers

Breast Cancer Research
Cancer ResearchOncology
2020English

miRNA Expression Profiling of Hereditary Breast Tumors From BRCA1- And BRCA2-germline Mutation Carriers in Brazil

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy